It is also worth highlighting the impact of hippurate over PPAR signaling pathway in BRCA model (Table S2), since circulating hippurate levels have been associated with pre-diagnosis risk to develop breast cancer in premenopausal women [72]; therefore, evaluating the production of hippurate can be a powerful tool in breast cancer risk management. This evidence concerns the gene PPARA and breast carcinoma.